Pascal Soriot

Type: Person
Name: Pascal Soriot
First reported 4 hours ago - Updated 4 hours ago - 1 reports

MARKET REPORT: Investors put their cash into a steady stream of IPOs

If help is on its way to the AIM market it can’t come quick enough.Dealers in the junior Alternative Investment Market have been complaining for weeks that overall daily trading volumes have slumped to just a trickle.Investors, in the hope of making a ... [Published This Is Money - 4 hours ago]
Entities: IPOs, FTSE, Iodine
First reported Apr 22 2014 - Updated 21 hours ago - 1 reports

AstraZeneca Stock Jumps on Takeover Reports

April 22nd, 2014 - 0 comments - Filed Under -by David AnicettiTweet[embedded content]Shares of AstraZeneca in the U.S. jumped in trading before the bell Monday after reports of a takeover approach of $100 billion by Pfizer, which would be the largest ... [Published Watch List News - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 3 reports

AstraZeneca ‘rejects Pfizer bid’

AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports.Both companies have declined to comment on a revealing Sunday Times article, but such an offer would make it a far bigger deal than the US company’s last major transaction, ... [Published Pharmafocus - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Don’t Bank On An AstraZeneca plc Bid Windfall

Shares in AstraZeneca (LSE:AZN) (NYSE: AZN) are currently up around 7% on weekend reports that Pfizer made a tentative bid approach. The newspapers are full of speculation while the City’s scribblers enthuse over the scope for costs savings, the potential ... [Published Interactive Investor - Apr 22 2014]
First reported Apr 20 2014 - Updated Apr 21 2014 - 3 reports

Drugs giant Pfizer mulling over a £60bn offer from AstraZeneca

It is understood that AstraZeneca rebuffed an initial approach from Pfizer, ending informal talks between the two companies.However, it is believed that Pfizer, best known for its anti-impotence treatment Viagra, may now be looking to revive negotiat ... [Published NewsRT.co.uk - Apr 21 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Russia may tighten criteria for the patentability of drugs

The Russian Federal Anti-Monopoly Service (FAS) is considering tightening the criteria of patentability, in order to reduce the effects of unreasonably granted drug patents in Russia.According to recent statements by the FAS, unjustified granting of patents ... [Published Pharma Letter - Apr 14 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 4 reports

AstraZeneca cozies up to MRC scientists amid an R&D rethink

AstraZeneca Executive Vice President Mene PangalosAstraZeneca ($AZN) isn't due to move into its new Cambridge, U.K., headquarters for another two years, but the British pharma giant is already laying the groundwork for open collaboration in the biomedical ... [Published FierceBiotech - Mar 31 2014]
First reported Mar 28 2014 - Updated Mar 29 2014 - 2 reports

AstraZeneca ramps up oncology pipeline

AstraZeneca’s Phase III pipeline is growing ahead of plan, chief executive Pascal Soriot told a recent media briefing, and cancer drugs make up a major chunk of the pipeline. In oncology, ... ... [Published Big News Network - Mar 29 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Soriot notches a bigger bonus but total $5.5M in pay is no record breaker

Pascal Soriot scored a big increase in bonus for 2013, but his total not only falls short of last year's, but pales by comparison with the biggest in Big Pharma. And his predecessor David ... ... [Published Big News Network - Mar 26 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

AstraZeneca PLC CEO Gets A Bigger Bonus In 2013

AstraZeneca boss Pascal Soriot was awarded a bumper bonus for 2013, equivalent to 94 per cent of the maximum the pharmaceuticals giant could have paid its CEO. The company’s annual report, published yesterday, cited several acquisitions that have bolstered ... [Published BioSpace - Mar 25 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

Soriot notches a bigger bonus, but total $5.5M in pay is no record breaker

AstraZeneca CEO Pascal SoriotAstraZeneca CEO Pascal Soriot scored a big increase in bonus for 2013, but his total not only falls short of last year's, but pales by comparison with the biggest in Big Pharma. And his predecessor David Brennan's pay beats ... [Published FiercePharma - Mar 24 2014]
First reported Mar 12 2014 - Updated Mar 13 2014 - 2 reports

AstraZeneca to sell Alderley Park

AstraZeneca says it will continue as a tenant on the site12/03/2014 Will remain as a life science innovation centreHelen TunnicliffeASTRAZENECA is selling its Alderley Park site in Cheshire, UK, to public-private partnership Manchester Science Parks ... [Published TCE Today - Mar 13 2014]

More Content

All (59) | News (56) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
MARKET REPORT: Investors put their cash into a ... [Published This Is Money - 4 hours ago]
AstraZeneca Stock Jumps on Takeover Reports [Published Watch List News - Apr 22 2014]
Don’t Bank On An AstraZeneca plc Bid Windfall [Published Interactive Investor - Apr 22 2014]
Don't Bank On An AstraZeneca plc Bid Windfall [Published Motley Fool UK - Apr 22 2014]
AstraZeneca ‘rejects Pfizer bid’ [Published Pharmafocus - Apr 22 2014]
AstraZeneca rises amid takeover talk [Published Interactive Investor - Apr 22 2014]
£150bn AstraZeneca-Pfizer merger mooted [Published Business Weekly UK - Apr 22 2014]
Pfizer, Inc. Rebuffed: Is AstraZeneca plc Worth... [Published Motley Fool Discussion Boards - Apr 21 2014]
AstraZeneca cancer pipeline seen as draw for Pf... [Published CNBC - Apr 21 2014]
Drugs giant Pfizer mulling over a £60bn offer f... [Published NewsRT.co.uk - Apr 21 2014]
Drugs giant Pfizer mulling over a £60bn offer f... [Published Daily Express - Apr 21 2014]
Viagra drug firm Pfizer mulls £60bn bid for str... [Published This Is Money - Apr 20 2014]
Pfizer eyes Astrazeneca to create industry giant [Published Telegraph - Apr 20 2014]
Pfizer-AstraZeneca takeover rumours prompt job ... [Published Guardian.co.uk - Apr 20 2014]
Report: Pfizer pitches $101B megamerger to stru... [Published FierceBiotech - Apr 20 2014]
Press: Viagra drug firm Pfizer has made a tenta... [Published This Is Money - Apr 20 2014]
Russia may tighten criteria for the patentabili... [Published Pharma Letter - Apr 14 2014]
Interview: AstraZeneca’s oncology expert Susan ... [Published Pharma Letter - Apr 11 2014]
Generic pains for AstraZeneca exacerbated by In... [Published Pharma Letter - Apr 07 2014]
Big Pharma dusts itself off in China scandal, b... [Published FiercePharma - Apr 03 2014]
What AstraZeneca plc’s Investment Plans Mean Fo... [Published Interactive Investor - Apr 03 2014]
GlaxoChinaGate contd. - how the reps were train... [Published PharmaGossip - Apr 02 2014]
AstraZeneca cozies up to MRC scientists amid an... [Published FierceBiotech - Mar 31 2014]
AstraZeneca to build drug discovery centre in C... [Published Invezz - Mar 31 2014]
AstraZeneca and MRC partner for new UK facility [Published Pharmafocus - Mar 31 2014]
AstraZeneca digs into new Cambridge home with M... [Published CNBC - Mar 31 2014]
AstraZeneca ramps up oncology pipeline [Published Big News Network - Mar 29 2014]
AstraZeneca Has a Promising Oncology Pipeline [Published American Journal of Managed Care - Mar 28 2014]
AstraZeneca ramps up oncology pipeline [Published Pharma Times - Mar 28 2014]
Park and Strive [Published Cheshire Independent - Mar 27 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
GlaxoChinaGate contd. - how the reps were train... [Published PharmaGossip - Apr 02 2014]
Big pharma’s rise in China not held back by scandals ©Getty Images When Chinese authorities accused GlaxoSmithKline  last summer of being the “godfather” at the centre of a network of corruption, big pharma braced for a prolonged period of turmoil in ...
AstraZeneca suffers more job cuts amid competit... [Published PharmaGossip - Feb 07 2014]
AstraZeneca is cutting another 550 roles around the world on top of more than 5,000 previous cuts as it looks to ramp up annual savings to £675million. It said the extra jobs cull, which it has already revealed to staff, would affect UK workers in ...
Frontrunning: January 31 [Published Zero Hedge - Jan 31 2014]
Even Obama's fans has turning on him: " The Decline and Fall of 'Hope and Change '" European Stocks Drop, Head for Worst January Since 2009 ( BBG ) Euro-Area Inflation at 0.7% Builds Rate Pressure on ECB ( BBG ) Japan’s Inflation Accelerates as Abe Seeks ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.